can contribute to potent efficacy, a longer duration in plasma or even the focus on tissues may perhaps contribute to potent efficacy. As talked about because of the Xenon/Genentech team,a hundred and one compounds with sharp PK profiles (superior blood level peaks) would contribute to in vivo Co